Saxenda Injection
Saxenda Weight Loss Injection in Dubai, Abu Dhabi & Ras Al-Khaimah Book Appointment At Emirates Hospitals Weight Loss Clinic, our experts will ensure you are appropriately assessed ot ensure the evidence based weight loss medication is recommended for you. Saxenda, a GLP-1 receptor agonist, has emerged as a promising medication for individuals struggling with obesity or overweight. This innovative treatment offers a potential solution for those who have difficulty losing weight through diet and exercise alone.
What is Saxenda?
Saxenda is a once-daily injection that works by mimicking the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone helps regulate appetite, blood sugar levels, and digestion. By mimicking GLP-1, Saxenda can help reduce hunger, increase feelings of fullness, and slow down the emptying of the stomach.
Why is Saxenda Prescribed?
Saxenda is prescribed to individuals with obesity or overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It is intended to help people lose weight and maintain weight loss over time.
Benefits of Saxenda
- Significant Weight Loss: Studies have shown that Saxenda can help individuals lose a significant amount of weight
- Improved Blood Sugar Control: For individuals with type 2 diabetes, Saxenda can help improve blood sugar control.
- Reduced Risk of Heart Disease by helping to lower body weight and improve other health factors.
Risks of Saxenda
There are always potential side effects with weight loss medications, which normally improve over times. some of these include:
- Nausea
- Vomiting & diarrhea
- Constipation
- Stomach pain
Determining the Right Medication for You
Our expert Endocrinologists, Internal Medicine Specialists and Family Medicine Consultants will determine the best weight loss medication for you catered to your individual circumstances, including your weight, health conditions, and preferences.
Frequently Asked Questions
While Saxenda, Wegovy, Mounjaro, and Ozempic are all GLP-1 receptor agonists, they have some key differences:
- Dosage: Saxenda is administered once daily, while Wegovy can be administered either once weekly or once monthly. Mounjaro and Ozempic are administered once weekly.
- Combination vs. Single Agent: Mounjaro is a combination of two GLP-1 receptor agonists (GLP-1 and GIP), while Saxenda, Wegovy, and Ozempic are single agents.
- Approval: Saxenda, Wegovy, and Ozempic are specifically approved for weight management, while Mounjaro is primarily approved for the treatment of type 2 diabetes.
Request an appointment
Please complete the details and we will book you shortly.
Request an appointment
Please complete the details and we will book you shortly.